Ngā hua rapu - Kwok, Kenneth
- E whakaatu ana i te 1 - 20 hua o te 28
- Haere ki te Whārangi Whai Ake
-
1
A retrospective, pooled data analysis of the safety of pegaptanib sodium in the treatment of age-related macular degeneration in subjects with or without diabetes mellitus mā Dombi, Theresa, Kwok, Kenneth K, Sultan, Marla B
I whakaputaina 2012Text -
2
Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis mā Fleischmann, Roy, Strand, Vibeke, Wilkinson, Bethanie, Kwok, Kenneth, Bananis, Eustratios
I whakaputaina 2016Text -
3
-
4
-
5
Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib mā Bird, Paul, Hall, Stephen, Nash, Peter, Connell, Carol A, Kwok, Kenneth, Witcombe, David, Thirunavukkarasu, Krishan
I whakaputaina 2019Text -
6
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studi... mā Fleischmann, Roy, Wollenhaupt, Jürgen, Takiya, Liza, Maniccia, Anna, Kwok, Kenneth, Wang, Lisy, van Vollenhoven, Ronald F
I whakaputaina 2017Text -
7
Dopaminergic Polymorphisms Associated with Time-on-Task Declines and Fatigue in the Psychomotor Vigilance Test mā Lim, Julian, Ebstein, Richard, Tse, Chun-Yu, Monakhov, Mikhail, Lai, Poh San, Dinges, David F., Kwok, Kenneth
I whakaputaina 2012Text -
8
Tofacitinib with conventional synthetic disease‐modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient‐reported outcomes from a Phase 3 randomized con... mā Li, Zhanguo, An, Yuan, Su, Houheng, Li, Xiangpei, Xu, Jianhua, Zheng, Yi, Li, Guiye, Kwok, Kenneth, Wang, Lisy, Wu, Qizhe
I whakaputaina 2018Text -
9
Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis mā Rubin, David T., Modesto, Irene, Vermeire, Séverine, Danese, Silvio, Ng, Siew C., Kwok, Kenneth K., Koram, Nana, Jones, Thomas V.
I whakaputaina 2021Text -
10
Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population mā Hall, Stephen, Nash, Peter, Rischmueller, Maureen, Bossingham, David, Bird, Paul, Cook, Nicola, Witcombe, David, Soma, Koshika, Kwok, Kenneth, Thirunavukkarasu, Krishan
I whakaputaina 2018Text -
11
Assessment of radiographic progression in patients with rheumatoid arthritis treated with tofacitinib in long-term studies mā van der Heijde, Désirée, Landewé, Robert B M, Wollenhaupt, Jürgen, Strengholt, Sander, Terry, Ketti, Kwok, Kenneth, Wang, Lisy, Cohen, Stanley
I whakaputaina 2020Text -
12
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials mā Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu
I whakaputaina 2020Text -
13
Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials mā Panaccione, Remo, Isaacs, John D., Chen, Lea Ann, Wang, Wenjin, Marren, Amy, Kwok, Kenneth, Wang, Lisy, Chan, Gary, Su, Chinyu
I whakaputaina 2020Text -
14
Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme mā Curtis, Jeffrey R, Lee, Eun Bong, Kaplan, Irina V, Kwok, Kenneth, Geier, Jamie, Benda, Birgitta, Soma, Koshika, Wang, Lisy, Riese, Richard
I whakaputaina 2016Text -
15
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs mā Charles-Schoeman, Christina, Burmester, Gerd, Nash, Peter, Zerbini, Cristiano A F, Soma, Koshika, Kwok, Kenneth, Hendrikx, Thijs, Bananis, Eustratios, Fleischmann, Roy
I whakaputaina 2016Text -
16
Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis mā Fleischmann, Roy M, Huizinga, Tom W J, Kavanaugh, Arthur F, Wilkinson, Bethanie, Kwok, Kenneth, DeMasi, Ryan, van Vollenhoven, Ronald F
I whakaputaina 2016Text -
17
Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment mā Winthrop, Kevin L., Curtis, Jeffrey R., Yamaoka, Kunihiro, Lee, Eun Bong, Hirose, Tomohiro, Rivas, Jose L., Kwok, Kenneth, Burmester, Gerd R.
I whakaputaina 2021Text -
18
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Se... mā Mueller, Ruediger B., Schulze-Koops, Hendrik, Furst, Daniel E., Cohen, Stanley B. , Kwok, Kenneth, Wang, Lisy, Killeen, Tim, von Kempis, Johannes
I whakaputaina 2022Text -
19
Long-Term Radiographic and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Treated with Tofacitinib: ORAL Start and ORAL Scan Post-hoc Analyses mā Strand, Vibeke, Kavanaugh, Arthur, Kivitz, Alan J., van der Heijde, Désirée, Kwok, Kenneth, Akylbekova, Ermeg, Soonasra, Arif, Snyder, Mark, Connell, Carol, Bananis, Eustratios, Smolen, Josef S.
I whakaputaina 2018Text -
20
Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management mā Sands, Bruce E, Colombel, Jean-Frédéric, Ha, Christina, Farnier, Michel, Armuzzi, Alessandro, Quirk, Daniel, Friedman, Gary S, Kwok, Kenneth, Salese, Leonardo, Su, Chinyu, Taub, Pam R
I whakaputaina 2020Text